These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38772679)

  • 1. Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort.
    Ciaffi J; Liem SIE; Cannegieter S; Ahmed S; Hoekstra EM; Wiland P; Atsumi T; Szücs G; Balbir Gurman A; Czirják L; Zanatta E; Koetter I; Henes JC; Matucci-Cerinic M; Airò P; Ursini F; Huizinga TWJ; De Vries-Bouwstra J; Collaborators E
    RMD Open; 2024 May; 10(2):. PubMed ID: 38772679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts.
    Liem SIE; Boonstra M; le Cessie S; Riccardi A; Airo P; Distler O; Matucci-Cerinic M; Caimmi C; Siegert E; Allanore Y; Huizinga TWJ; Toes REM; Scherer HU; de Vries-Bouwstra JK;
    Lancet Rheumatol; 2022 Oct; 4(10):e699-e709. PubMed ID: 38265968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking and systemic sclerosis: influence on microangiopathy and expression of anti-topoisomerase I antibodies in a monocentric cohort.
    Ciaffi J; van Leeuwen NM; Huizinga TWJ; de Vries-Bouwstra JK
    Clin Exp Rheumatol; 2020; 38 Suppl 125(3):25-28. PubMed ID: 32242801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.
    Heijnen IA; Foocharoen C; Bannert B; Carreira PE; Caporali R; Smith V; Kumánovics G; Becker MO; Vanthuyne M; Simsek I; Bocelli-Tyndall C; Walker UA
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):96-102. PubMed ID: 23101460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
    Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
    Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
    Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
    Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study.
    Jaeger VK; Valentini G; Hachulla E; Cozzi F; Distler O; Airó P; Czirják L; Allanore Y; Siegert E; Rosato E; Matucci-Cerinic M; Caimmi C; Henes J; Carreira PE; Smith V; Del Galdo F; Denton CP; Ullman S; De Langhe E; Riccieri V; Alegre-Sancho JJ; Rednic S; Müller-Ladner U; Walker UA;
    Arthritis Rheumatol; 2018 Nov; 70(11):1829-1834. PubMed ID: 29781588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To what extent do autoantibodies help to identify high-risk patients in systemic sclerosis?
    Boonstra M; Mertens BJA; Bakker JA; Ninaber MK; Ajmone Marsan N; van der Helm-van Mil AHM; Scherer HU; Huizinga TWJ; de Vries-Bouwstra JK
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):109-117. PubMed ID: 30148428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study.
    Jaeger VK; Tikly M; Xu D; Siegert E; Hachulla E; Airò P; Valentini G; Matucci Cerinic M; Distler O; Cozzi F; Carreira P; Allanore Y; Müller-Ladner U; Ananieva LP; Balbir-Gurman A; Distler JHW; Czirják L; Li M; Henes J; Jimenez SA; Smith V; Damjanov N; Denton CP; DelGaldo F; Saketkoo LA; Walker UA;
    Rheumatology (Oxford); 2020 Jul; 59(7):1684-1694. PubMed ID: 31680161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.
    Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Centromere- and Topoisomerase-specific Immune Responses and the Degree of Microangiopathy in Systemic Sclerosis.
    van Leeuwen NM; Wortel CM; Fehres CM; Bakker JA; Scherer HU; Toes REM; Huizinga TWJ; de Vries-Bouwstra JK
    J Rheumatol; 2021 Mar; 48(3):402-409. PubMed ID: 32482649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.
    Iniesta Arandia N; Simeón-Aznar CP; Guillén Del Castillo A; Colunga Argüelles D; Rubio-Rivas M; Trapiella Martínez L; García Hernández FJ; Sáez Comet L; Egurbide Arberas MV; Ortego-Centeno N; Freire M; Marí Alfonso B; Vargas Hitos JA; Ríos Blanco JJ; Todolí Parra JA; Rodríguez-Carballeira M; Marín Ballvé A; Chamorro Fernández AJ; Pla Salas X; Madroñero Vuelta AB; Ruiz Muñoz M; Fonollosa Pla V; Espinosa G;
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):98-105. PubMed ID: 28980912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High anti-topoisomerase-1 autoantibodies levels are associated with the extension of skin fibrosis and vascular progression in patients with systemic sclerosis].
    Dol C; Granel B; Resseguier N; Kaplanski G; Reynaud-Gaubert M; Schleinitz N; Grob JJ; Delaporte E; Lafforgue P; Rossi P; Bardin N; Benyamine A
    Rev Med Interne; 2024 Mar; 45(3):126-131. PubMed ID: 38355359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies.
    Liem SIE; Neppelenbroek S; Fehres CM; Wevers BA; Toes REM; Allaart CF; Huizinga TWJ; Scherer HU; De Vries-Bouwstra JK
    RMD Open; 2023 Feb; 9(1):. PubMed ID: 36746531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.
    Zanatta E; Huscher D; Ortolan A; Avouac J; Airò P; Balbir-Gurman A; Siegert E; Matucci Cerinic M; Cozzi F; Riemekasten G; Hoffmann-Vold AM; Distler O; Gabrielli A; Heitmann S; Hunzelmann N; Montecucco C; Morovic-Vergles J; Ribi C; Doria A; Allanore Y;
    Rheumatology (Oxford); 2022 Nov; 61(12):4786-4796. PubMed ID: 35348643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations.
    Gourh P; Arnett FC; Assassi S; Tan FK; Huang M; Diekman L; Mayes MD; Reveille JD; Agarwal SK
    Arthritis Res Ther; 2009; 11(5):R147. PubMed ID: 19799786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking is not a risk factor for systemic sclerosis.
    Chaudhary P; Chen X; Assassi S; Gorlova O; Draeger H; Harper BE; Gonzalez E; McNearney T; Perry M; Arnett FC; Mayes MD
    Arthritis Rheum; 2011 Oct; 63(10):3098-102. PubMed ID: 21647865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and organ involvement in patients with limited cutaneous systemic sclerosis and anti-topoisomerase-I antibodies: determined by skin subtype or auto-antibody subtype? A long-term follow-up study.
    Kranenburg P; van den Hombergh WM; Knaapen-Hans HK; van den Hoogen FH; Fransen J; Vonk MC
    Rheumatology (Oxford); 2016 Nov; 55(11):2001-2008. PubMed ID: 27520796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Smoking Status With Mortality and Hospitalization in Hemodialysis Patients.
    Li NC; Thadhani RI; Reviriego-Mendoza M; Larkin JW; Maddux FW; Ofsthun NJ
    Am J Kidney Dis; 2018 Nov; 72(5):673-681. PubMed ID: 29909936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis.
    Cottrell TR; Wise RA; Wigley FM; Boin F
    Ann Rheum Dis; 2014 Jun; 73(6):1060-6. PubMed ID: 23606705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.